{
    "doi": "https://doi.org/10.1182/blood.V110.11.4104.4104",
    "article_title": "3D Grown Human Placental-Derived Mesenchymal Stromal Cells (PLX-I) Support and Potentiate the Engraftment of Human Cord Blood Unfractionated (UFCBC) and Fractionated CD34+ Cells (hCD34+) in Irradiated NOD/SCID Mice. ",
    "article_date": "November 16, 2007",
    "session_type": "Publication Only",
    "abstract_text": "The use of human umbilical cord blood (hUCB) for transplantation (CBT) in adults is limited due to the low cell number in each unit. Engraftment rates are lower and the time to neutrophils and platelet recovery is longer following CBT compared to bone marrow (BM) transplantation (28 vs 14 days, respectively). Co-transplantation of human hematopoietic stem/progenitor cells (hHSC) with mesenchymal stromal cells in an irradiated NOD/SCID mice model has been demonstrated to promote HSC engraftment. In a typical clinical setting of CBT, unfractionated cord blood cells (UFCBC) are usually used. On the other hand, in the irradiated NOD/SCID mice model, the CD34+ enriched fraction is usually used. Therfore, performing pre-clinical studies using UFCBC would better reflect the outcome in the clinical setting. Using PluriX technology, we expanded human placental derived mesenchymal stromal cells on 3D carriers in a bioreactor (PLX-I) and evaluated their potential to promote the engraftment of UFCBC or hUCB derived fractionated CD34+ cells (hCD34+) in NOD/SCID mice. UFCBC (10 7 ) or hCD34+ (5\u00d710 4 ) were injected into the tail vein of 7\u20138 week old NOD/SCID mice along with 0.5\u00d710 6 or 1\u00d710 6 PLX-I cells. Following 5\u20136 weeks, FACS analysis of % human CD45+ cells in mice BM demonstrated that in the PLX-I untreated mice, the 10 7 UFCBC engrafted in a lower rate compare to 5*10 4 hCD34+ (6.28% vs. 14.43% respectively, n=10). Furthermore, in both settings, hCD34+ and UFCBC, the addition of PLX-I enhanced the hHSC engraftment 1.7 and 2 fold respectively compared to PLX-I untreated mice (24.13% vs. 14.43% in hCD34+ setting and 12.85% vs. 6.28% in UFCBC setting, n=10). We conclude that UFCBC can be used for hHSC engraftment in NOD/SCID mice model and co-transplantation of these cells with PLX-I may serve as a promising approach for the improvement of the hitherto delayed engraftment following cord blood transplantation.",
    "topics": [
        "engraftment",
        "placenta",
        "scid mice",
        "stem cell, mesenchymal",
        "transplantation",
        "umbilical cord blood",
        "umbilical cord blood transplantation",
        "cell count",
        "bioreactors",
        "mice"
    ],
    "author_names": [
        "Ora Burger",
        "Osnat M. Jacov",
        "Nirit D. Carmi",
        "Galit F. Ashtamker",
        "Lena Pinzur",
        "Einat Mizrachi",
        "Marina Rusanovsky",
        "Noam Bercovich",
        "Ofer B. Moshe",
        "Limor Lior",
        "Moran Meiron",
        "William R. Prather",
        "Shai Meretzki",
        "Avi J. Treves",
        "Avinoam Kadouri",
        "Jacob M. Rowe",
        "Edwin M. Horwitz",
        "Arnon Nagler"
    ],
    "author_dict_list": [
        {
            "author_name": "Ora Burger",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Osnat M. Jacov",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nirit D. Carmi",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Galit F. Ashtamker",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lena Pinzur",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Einat Mizrachi",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marina Rusanovsky",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Noam Bercovich",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ofer B. Moshe",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Limor Lior",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Moran Meiron",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "William R. Prather",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Shai Meretzki",
            "author_affiliations": [
                "MATAM Advanced Technology Park, #20, Pluristem Life Systems Inc, Haifa, Israel",
                " "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Avi J. Treves",
            "author_affiliations": [
                "Sheba Medical Center, Tel Hashomer, Israel",
                " "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Avinoam Kadouri",
            "author_affiliations": [
                "Rainbow Biotechnologies, Lausanne, Swaziland",
                " "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jacob M. Rowe",
            "author_affiliations": [
                "Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel",
                "Rambam Medical Center, Haifa, Israel",
                " "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Edwin M. Horwitz",
            "author_affiliations": [
                "The Children\u2019s Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, PA, USA",
                " "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Arnon Nagler",
            "author_affiliations": [
                "Sheba Medical Center, Tel Hashomer, Israel",
                " "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-06T03:46:30",
    "is_scraped": "1"
}